The COOH-terminal domain of wild-type cot regulates its stability and kinase specific activity

被引:46
作者
Gándara, ML [1 ]
López, P [1 ]
Hernando, R [1 ]
Castaño, JG [1 ]
Alemany, S [1 ]
机构
[1] UAM, CSIC, Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient,Fac Med, Madrid 28029, Spain
关键词
D O I
10.1128/MCB.23.20.7377-7390.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cot, initially identified as an oncogene in a truncated form, is a mitogen-activated protein kinase kinase kinase implicated in cellular activation and proliferation. Here, we show that this truncation of Cot results in a 10-fold increase in its overall kinase activity through two different mechanisms. Truncated Cot protein exhibits a lower turnover rate (half-life, 95 min) than wild-type Cot (half-life, 35 min). The degradation of wild-type and truncated Cot can be specifically inhibited by proteasome inhibitors in situ. The 20S proteasome also degrades wild-type Cot more efficiently than the truncated protein. Furthermore, the amino acid 435 to 457 region within the wild-type Cot COOH-terminal domain confers instability when transferred to the yellow fluorescent protein and targets this fusion protein to degradation via the proteasome. On the other hand, the kinase specific activity of wild-type Cot is 3.8-fold lower than that of truncated Cot, and it appears that the last 43 amino acids of the wild-type Cot COOH-terminal domain are those responsible for this inhibition of kinase activity. In conclusion, these data demonstrate that the oncogenic activity of truncated Cot is the result of its prolonged half-life and its higher kinase specific activity with respect to wild-type Cot.
引用
收藏
页码:7377 / 7390
页数:14
相关论文
共 71 条
[61]  
STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106
[62]   A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome [J].
Touitou, R ;
Richardson, J ;
Bose, S ;
Nakanishi, M ;
Rivett, J ;
Allday, MJ .
EMBO JOURNAL, 2001, 20 (10) :2367-2375
[63]   UBIQUITIN-DEPENDENT C-JUN DEGRADATION IN-VIVO IS MEDIATED BY THE DELTA-DOMAIN [J].
TREIER, M ;
STASZEWSKI, LM ;
BOHMANN, D .
CELL, 1994, 78 (05) :787-798
[64]   Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-κB [J].
Tsatsanis, C ;
Patriotis, C ;
Tsichlis, PN .
ONCOGENE, 1998, 17 (20) :2609-2618
[65]   The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines [J].
Tsatsanis, C ;
Patriotis, C ;
Bear, SE ;
Tsichlis, PN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3827-3832
[66]   NAMING A TARGETING SIGNAL [J].
VARSHAVSKY, A .
CELL, 1991, 64 (01) :13-15
[67]   P27kif protein levels and E2F activity are targets of Cot kinase during G1 phase progression in T cells [J].
Velasco-Sampayo, A ;
Alemany, S .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6084-6090
[68]   A proteasome howdunit: The case of the missing signal [J].
Verma, R ;
Deshaies, RJ .
CELL, 2000, 101 (04) :341-344
[69]   Selective degradation of ubiquitinated Sic1 by purified 26S proteasome yields active S phase cyclin-Cdk [J].
Verma, R ;
McDonald, H ;
Yates, JR ;
Deshaies, RJ .
MOLECULAR CELL, 2001, 8 (02) :439-448
[70]   The 26S proteasome: A molecular machine designed for controlled proteolysis [J].
Voges, D ;
Zwickl, P ;
Baumeister, W .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :1015-1068